ProThera and WIH receive $1.95M in grant money

PROTHERA BIOLOGICS and Women & Infants Hospital were awarded $1.95 million to continue research into the medical potential of Inter-Alpha Inhibitor Proteins. Pictured is ProThera founder and CEO Yow-Pin Lim. / PBN FILE PHOTO/TRACY JENKINS
PROTHERA BIOLOGICS and Women & Infants Hospital were awarded $1.95 million to continue research into the medical potential of Inter-Alpha Inhibitor Proteins. Pictured is ProThera founder and CEO Yow-Pin Lim. / PBN FILE PHOTO/TRACY JENKINS
Updated at 3:08 p.m. PROVIDENCE - ProThera Biologics and Women & Infants Hospital were awarded a $1.95 million Phase II Small Business Innovation Research grant from the National Institutes of Health to study the potential of Inter-Alpha Inhibitor Proteins to prevent and treat neonatal hypoxic ischemic brain injury, the company announced on Monday. ProThera and…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -